Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Zuellig Pharma Acquires Licensed Pharmaceutical Entity and Facility in Hangzhou, China – Strategic Move Strengthens Clinical Trial Sourcing Capabilities
CompanyDeals

Zuellig Pharma Acquires Licensed Pharmaceutical Entity and Facility in Hangzhou, China – Strategic Move Strengthens Clinical Trial Sourcing Capabilities

Zuellig Pharma, a leading healthcare services company in Asia, announced the strategic acquisition of a pharmaceutical entity and its facility in Hangzhou, China, holding a Drug Distribution License (DDL) —…

Alfasigma Reclaims Sulodexide Rights in China – Business Transfer to Add €25 Million in Annual Revenue and Drive 30 % Expansion of Alfasigma China

Alfasigma Reclaims Sulodexide Rights in China – Business Transfer to Add €25 Million in Annual Revenue and Drive 30 % Expansion of Alfasigma China

Bayer Q3 2026 Sales Reach €10.053 Billion as Pharmaceuticals Division Hits Growth Turning Point – Nubeqa and Kerendia Lead the Rebound

Bayer Q3 2026 Sales Reach €10.053 Billion as Pharmaceuticals Division Hits Growth Turning Point – Nubeqa and Kerendia Lead the Rebound

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

BeiGene’s Tislelizumab Approved in China for First-Line Esophageal Squamous Cell Carcinoma

CompanyDrug

Bayer’s Copanlisib (Aliqopa) Approved by NMPA for Recurrent Follicular Lymphoma

CompanyDrug

Shanghai Junshi Biosciences’ Tuoyi Combo for Triple Negative Breast Cancer Accepted for Review

CompanyDrug

Sino-US Laekna Receives FDA Clearance for LAE102 Clinical Trial in NSCLC

CompanyDeals

Asieris Pharmaceuticals Secures Exclusive Global Rights to UroViu’s Fluorescent Imaging Cystoscope

CompanyDrug

FibroGen’s Roxadustat Shows Positive Results in Phase III Chemotherapy-Induced Anemia Trial

CompanyDrug

Betta Pharmaceuticals Initiates Phase I/II Study for First-In-Class BsAb BPB-101

CompanyDrug

Antengene’s First-in-Class CD24 mAb ATG-031 Gets US FDA Approval for Phase I Study

Show More